> top > docs > PMC:7784786 > spans > 6453-7094 > annotations

PMC:7784786 / 6453-7094 JSONTXT

Annnotations TAB JSON ListView MergeView

LitCovid-PubTator

Id Subject Object Predicate Lexical cue tao:has_database_id
234 21-31 Chemical denotes itolizumab MESH:C000597346
235 167-177 Chemical denotes itolizumab MESH:C000597346
236 390-400 Chemical denotes itolizumab MESH:C000597346
237 517-527 Chemical denotes itolizumab MESH:C000597346
238 139-155 Disease denotes pleural effusion MESH:D010996
239 342-358 Disease denotes pleural effusion MESH:D010996

LitCovid-PD-HP

Id Subject Object Predicate Lexical cue hp_id
T17 139-155 Phenotype denotes pleural effusion http://purl.obolibrary.org/obo/HP_0002202
T18 342-358 Phenotype denotes pleural effusion http://purl.obolibrary.org/obo/HP_0002202

LitCovid-sentences

Id Subject Object Predicate Lexical cue
T59 0-127 Sentence denotes Patient 1 (A) Before itolizumab (D0): diffuse Interstitial-alveolar infiltrate in both lung fields, predominantly in the bases.
T60 128-331 Sentence denotes Minor left pleural effusion. (B) After itolizumab (48 h): radiological improvement with decreased diffuse infiltrate and radio-opacity at the top of both lungs and in both lung bases, in less proportion.
T61 332-368 Sentence denotes The minor pleural effusion persists.
T62 369-641 Sentence denotes Patient 3 (C) Before itolizumab (D0): alveolar interstitial inflammatory infiltrate in both lung fields, predominantly on the right side. (D) After itolizumab (48 h): radiological improvement with significant decrease of the alveolar interstitial infiltrate of both lungs.